Skip to content
Menu

HC Wainwright & Co. Maintains Buy on LifeMD, Lowers Price Target to $6

Benzinga Newsdesk 2 days ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $9 to $6.

HC Wainwright & Co. analyst Yi Chen maintains LifeMD (NASDAQ:LFMD) with a Buy and lowers the price target from $9 to $6.

Read at benzinga.com

← All stock news